Back

Q32 Bio names medical and development chiefs as bempikibart advances

Verifying
  • Q32 Bio Inc. appointed Dr. José Trevejo and Dr. Ellie Hershberger to senior clinical roles.
  • Bempikibart is being advanced as a treatment targeting severe alopecia.
  • Q32 Bio is transitioning its development program to the late-stage clinical phase.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Q32 Bio names medical and development chiefs as bempikibart advances - CoinPost Terminal